Placebo sublingual

DRUG4 trials

Sponsors

Azienda Sanitaria dell'Alto Adige, Inmunotek S.L.

Conditions

Acute Pain Due to TraumaAllergic AsthmaAllergic RhinitisAllergic RhinoconjunctivitisAllergy to House Dust MiteHouse Dust Mite AllergyPerennial Allergic Rhinitis

Phase 2

Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract

Not yet recruitingNCT05641272

Inmunotek S.L.Allergic Asthma, Allergic Rhinitis, Allergic Rhinoconjunctivitis +1

Start: 2023-11-01End: 2026-12-01Target: 90Updated: 2023-10-23

Phase 3

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Inmunotek S.L.Allergic Asthma, Allergic Rhinoconjunctivitis, House Dust Mite Allergy +1

Start: 2022-12-31End: 2025-07-31Target: 400Updated: 2022-11-18

Phase 4

Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope

CompletedNCT03080350

Azienda Sanitaria dell'Alto AdigeAcute Pain Due to Trauma

Start: 2017-01-31End: 2018-03-31Updated: 2020-03-04

Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room

CompletedNCT03080324

Azienda Sanitaria dell'Alto AdigeAcute Pain Due to Trauma

Start: 2016-12-01End: 2017-05-15Updated: 2020-03-04